[1]陈康康,张志宇,张艺佳,等.新型镇静药物瑞马唑仑临床应用研究进展[J].陕西医学杂志,2023,52(8):1106-1109.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.038]
 CHEN Kangkang,ZHANG Zhiyu,ZHANG Yijia,et al.Research progress of clinical application of new sedative Remimazolam[J].,2023,52(8):1106-1109.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.038]
点击复制

新型镇静药物瑞马唑仑临床应用研究进展
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年8期
页码:
1106-1109
栏目:
综 述
出版日期:
2023-08-05

文章信息/Info

Title:
Research progress of clinical application of new sedative Remimazolam
作者:
陈康康1张志宇2张艺佳1梁映霞1
(1.潍坊医学院麻醉学院,山东 潍坊 261053; 2.潍坊医学院附属医院创伤外科,山东 潍坊261035)
Author(s):
CHEN KangkangZHANG ZhiyuZHANG YijiaLIANG Yingxia
(College of Anesthesiology,Weifang Medical College,Weifang 261053,China)
关键词:
瑞马唑仑 麻醉 镇静药 重症监护 苯二氮卓 药理学
Keywords:
Remazolam Anesthesia Sedative drugs Intensive care Benzenediazonium Pharmacology
分类号:
R 169.42
DOI:
DOI:10.3969/j.issn.1000-7377.2023.08.038
文献标志码:
A
摘要:
新型镇静药物甲苯磺酸瑞马唑仑(简称瑞马唑仑)作为一种超短效苯二氮卓类药物,具备起效快和恢复快,呼吸抑制轻、血流动力学稳定、长时间输注无蓄积、可被拮抗剂氟马西尼快速逆转、不依赖肝肾代谢、代谢物无药理活性等优点,已逐渐成为用于各种临床实践的潜在镇静药物。现就瑞马唑仑的药理学特性及其在无痛内镜检查、围术期全身麻醉、重症监护病房(ICU)镇静、不良反应等临床应用问题作一综述,为其临床安全用药提供参考。
Abstract:
The new sedative remimazolam besylate(remimazolam),as an ultra-short-acting benzodiazepine,has the advantages of quick onset and fast recovery,mild respiratory depression,stable hemodynamics,no accumulation after long-term infusion,rapid reversal by antagonist flumazenil,independent of liver and kidney metabolism,and no pharmacological activity of metabolites.It has gradually become a potential sedative for various clinical practices.This article reviews the pharmacological characteristics of remimazolam and its clinical application in painless endoscopy,general anesthesia during the perioperative period,sedation in ICU,adverse reactions,in order to provide reference for its clinical safety.

参考文献/References:

[1] 刘 鹏,梁 赟,张闪闪,等.瑞马唑仑与丙泊酚应用于无痛胃肠镜安全性及有效性Meta分析[J].陕西医学杂志,2022,51(6):753-759.
[2] 邓亚南,潘小妮,刘 鑫,等.针刺与腰丛神经阻滞在全髋关节置换术患者超前镇痛中的应用比较[J].陕西中医,2022,43(10):1455-1458.
[3] 赵 娟,陈金权.瑞马唑仑对老年大鼠海马B淋巴细胞瘤-2、一氧化氮合酶蛋白表达及神经元凋亡和认知功能的影响[J].陕西医学杂志,2022,51(3):289-292.
[4] 滕云鹏,何家璇,李思远,等.瑞马唑仑联合帕瑞昔布钠在老年患者经皮椎间孔镜下髓核摘除术中的麻醉效果及安全性研究[J].陕西医学杂志,2021,50(12):1562-1565,1569.
[5] Rogers WK,Dowell TS.Remimazolam:A short-acting GABA(A)receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures[J].I Drugs,2010,13(12):929-937.
[6] Goudra BG,Singh PM.Remimazolam:The future of its sedative potential[J].Saudi J Anaesth,2014,8(3):388-391.
[7] Kilpatrick GJ.Remimazolam:Non-clinical and clinical profile of a new sedative/anesthetic agent[J].Frontiers in Pharmacology,2021,12:690875.
[8] Zhou Y,Hu P,Jiang J.Metabolite characterization of a novel sedative drug,remimazolam in human plasma and urine using ultra high-performance liquid chromatography coupled with synapt high-definition mass spectrometry[J].J Pharm Biomed Anal,2017,137:78-83.
[9] Antonik LJ,Goldwater DR,Kilpatrick GJ,et al.A placebo-and midazolam-controlled phase I single ascending-dose study evaluating the safety,pharmacokinetics,and pharmacodynamics of remimazolam(CNS 7056):Part I.safety,efficacy,and basic pharmacokinetics[J].Anesth Analg,2012,115(2):274-283.
[10] Schuttler J,Eisenried A,Lerch M,et al.Pharmacokinetics and pharmacodynamics of remimazolam(cns 7056)after continuous infusion in healthy male volunteers:Part I.pharmacokinetics and clinical pharmacodynamics[J].Anesthesiology,2020,132(4):636-651.
[11] Lohmer LL,Schippers F,Petersen KU,et al.Time-to-event modeling for remimazolam for the indication of induction and maintenance of general anesthesia[J].J Clin Pharmacol,2020,60(4):505-514.
[12] 张 力,李方玲,马 丽,等.电针联合马来酸咪达唑仑改善阿尔茨海默病睡眠障碍临床观察[J].陕西中医,2017,38(10):1471-1472.
[13] Dou D,Feng Y,Jiang L.Efficiency and safety of remimazolam and midazolam in digestive endoscopic sedation:Systematic review and meta-analysis[J].Dig Endosc,2022,34(3):653.
[14] Liu X,Ding B,Shi F,et al.The efficacy and safety of remimazolam tosilate versus etomidate-propofol in elderly outpatients undergoing colonoscopy:A prospective,randomized,single-blind,non-inferiority trial[J].Drug Des Devel Ther,2021,15:4675-4685.
[15] Zhang S,Wang J,Ran R,et al.Efficacy and safety of remimazolam tosylate in hysteroscopy:A randomized,single-blind,parallel controlled trial[J].J Clin Pharm Ther,2022,47(1):55-60.
[16] Stohr T,Colin PJ,Ossig J,et al.Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment[J].Br J Anaesth,2021,127(3):415-423.
[17] Shi F,Chen Y,Li H,et al.Efficacy and safety of remimazolam tosilate versus propofol for general anesthesia in cirrhotic patients undergoing endoscopic variceal ligation[J].Int J Gen Med,2022,15:583-591.
[18] Morimoto Y.Efficacy and safety profile of remimazolam for sedation in adults undergoing short surgical procedures[J].Ther Clin Risk Manag,2022,18:95-100.
[19] Oka S,Satomi H,Sekino R,et al.Sedation outcomes for remimazolam,a new benzodiazepine[J].J Oral Sci,2021,63(3):209-211.
[20] Liu T,Lai T,Chen J,et al.Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery:A randomized,double-blind,controlled trial[J].Pharmacol Res Perspect,2021,9(5):851.
[21] Nakanishi T,Sento Y,Kamimura Y,et al.Remimazolam for induction of anesthesia in elderly patients with severe aortic stenosis:A prospective,observational pilot study[J].BMC Anesthesiol,2021,21(1):306.
[22] Tang F,Yi JM,Gong HY,et al.Remimazolam benzenesulfonate anesthesia effectiveness in cardiac surgery patients under general anesthesia[J].World J Clin Cases,2021,9(34):10595-10603.
[23] Hasegawa G,Hirata N,Yoshikawa Y,et al.Differential effects of remimazolam and propofol on heart rate variability during anesthesia induction[J].J Anesth,2022,36(2):239-245.
[24] Sato T,Kato Y,Yamamoto M,et al.Novel anesthetic agent remimazolam as an alternative for the asleep-awake-asleep technique of awake craniotomy[J].JA Clin Rep,2020,6(1):92.
[25] Horikoshi Y,Kuratani N,Tateno K,et al.Anesthetic management with remimazolam for a pediatric patient with duchenne muscular dystrophy[J].Medicine(Baltimore),2021,100(49):28209.
[26] Arashiro A,Shinzato H,Kamizato K,et al.Spinal fusion with motor evoked potential monitoring using remimazolam in Alstrom syndrome:A case report[J].Medicine(Baltimore),2021,100(47):27990.
[27] Nakayama J,Ogihara T,Yajima R,et al.Anesthetic management of super-elderly patients with remimazolam:A report of two cases[J].JA Clin Rep,2021,7(1):71.
[28] Suzuki Y,Doi M,Nakajima Y.General anesthesia with remimazolam in a patient with mitochondrial encephalomyopathy:A case report[J].JA Clin Rep,2021,7(1):51.
[29] Furuta M,Ito H,Yamazaki M.Anaesthetic management using remimazolam in a patient with severe aortic stenosis:A case report[J].BMC Anesthesiol,2021,21(1):202.
[30] Nishihara N,Tachibana S,Ikeshima M,et al.Remimazolam enabled safe anesthetic management during tracheostomy in a patient with amyotrophic lateral sclerosis:A case report[J].JA Clin Rep,2022,8(1):25.
[31] Wesolowski AM,Zaccagnino MP,Malapero RJ,et al.Remimazolam:Pharmacologic considerations and clinical role in anesthesiology[J].Pharmacotherapy,2016,36(9):1021-1027.
[32] Fang H,Zhang Y,Wang J,et al.Remimazolam reduces sepsis-associated acute liver injury by activation of peripheral benzodiazepine receptors and p38 inhibition of macrophages[J].Int Immunopharmacol,2021,101(11):108331.
[33] Liu X,Lin S,Zhong Y,et al.Remimazolam protects against LPS-induced endotoxicity improving survival of endotoxemia mice[J].Front Pharmacol,2021,12:739603.
[34] Anonymou U.Remimazolam(Byfavo)for short-term procedural sedation[J].Med Lett Drugs,2022,64(1644):26-28.
[35] Sasaki H,Hoshijima H,Mizuta K.Ringer's acetate solution-induced precipitation of remimazolam[J].Br J Anaesth,2021,126(3):87-89.
[36] Matsuo M,Okada K,Onuki Y,et al.Incompatibility of remimazolam besylate with Ringer's acetate infusion resulting in total occlusion of an intravenous catheter[J].BMJ Case Rep,2021,14(4):344-349.
[37] Yoshida K,Tanaka S,Watanabe K.A case of intravenous line occlusion when using Acetated Ringer's solution and remimazolam[J].J Clin Anesth,2021,70:110190.
[38] Uchida S,Takekawa D,Kitayama M,et al.Two cases of circulatory collapse due to suspected remimazolam anaphylaxis[J].JA Clin Rep,2022,8(1):18.
[39] Tsurumi K,Takahashi S,Hiramoto Y,et al.Remimazolam anaphylaxis during anesthesia induction[J].J Anesth,2021,35(4):571-575.
[40] Hari Y,Satomi S,Murakami C,et al.Remimazolam decreased the incidence of early postoperative nausea and vomiting compared to desflurane after laparoscopic gynecological surgery[J].J Anesth,2022,36(2):265-269.
[41] Zhang Y,Dai G,Xu H,et al.Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia:A reply[J].Minerva Anestesiol,2022,88(3):194-195.
[42] Schippers F,Pesic M,Saunders R,et al.Randomized crossover trial to compare abuse liability of intravenous remimazolam versus intravenous midazolam and placebo in recreational central nervous system depressant users[J].J Clin Pharmacol,2020,60(9):1189-1197.

相似文献/References:

[1]薛璋明,周绍文△,张 娟,等.羟考酮联合右美托咪定应用于区域麻醉镇静临床观察[J].陕西医学杂志,2020,49(2):231.
 XUE Zhangming,ZHOU Shaowen,ZHANG Juan,et al.Clinical observation of sedation under regional anesthesia with oxycodone combined with dexmedetomidine[J].,2020,49(8):231.
[2]霍建臻,刘 江△.右美托咪定在喉镜下声带手术麻醉中的应用效果分析[J].陕西医学杂志,2020,49(6):745.[doi:DOI:10.3969/j.issn.10007377.2020.06.026]
[3]刘 康,冯毅凡,田 道.胸腰筋膜平面阻滞对老年腰椎融合术患者术中阿片类麻醉剂用量及术后早期康复质量的影响[J].陕西医学杂志,2021,50(7):843.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.019]
[4]姚 琳,董小强.右美托咪定维持麻醉对腰后路减压植骨融合内固定术患者肝肾功能和术后认知功能的影响[J].陕西医学杂志,2021,50(7):867.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.026]
 YAO Lin,DONG Xiaoqiang.Effect of dexmedetomidine maintenance anesthesia on liver and kidney function and postoperative cognitive function in patients undergoing posterior lumbar decompression,bone graft fusion and internal fixation[J].,2021,50(8):867.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.026]
[5]王 雄,高芳芳,贺 峰.儿茶酚胺氧位甲基转移酶Val158met基因多态性与榆林地区妇科患者术后芬太尼镇痛效应关系研究[J].陕西医学杂志,2021,50(8):992.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.022]
 WANG Xiong,GAO Fangfang,HE Feng.Relationship between COMT Val158met gene polymorphism and analgesic effect of fentanyl in gynecological postoperative patients in Yulin area[J].,2021,50(8):992.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.022]
[6]孟繁思,刘 松,张 维,等.经鼻湿化快速通气交换技术用于临床麻醉气道管理研究进展[J].陕西医学杂志,2021,50(8):1031.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.032]
 MENG Fansi,LIU Song,ZHANG Wei,et al.Advances in transnasal humidified rapid-insufflation ventilatory exchangenasal for airway management of clinical anesthesia[J].,2021,50(8):1031.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.032]
[7]赵 娟,陈金权.瑞马唑仑对老年大鼠海马B淋巴细胞瘤-2、一氧化氮合酶蛋白表达及神经元凋亡和认知功能的影响[J].陕西医学杂志,2022,51(3):289.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.006]
 ZHAO Juan,CHEN Jinquan.Effects of remazolam on Bcl-2 and NOS protein expression, neuronal apoptosis and cognitive function in hippocampus of aged rats[J].,2022,51(8):289.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.006]
[8]张雅磊,李 伟,李光耀.地佐辛联合异丙酚麻醉对大鼠海马组织p38MAPK信号通路及认知功能的影响[J].陕西医学杂志,2022,51(5):556.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.010]
 ZHANG Yalei,LI Wei,LI Guangyao.Effects of dizosin combined with propofol on p38MAPK signal pathway and cognitive function in hippocampus of rats[J].,2022,51(8):556.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.010]
[9]刘 鹏,梁 贇,张闪闪,等.瑞马唑仑与丙泊酚应用于无痛胃肠镜安全性及有效性Meta分析[J].陕西医学杂志,2022,51(6):753.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.027]
 LIU Peng,LIANG Yun,ZHANG Shanshan,et al.Meta analysis of the safety and efficacy of remimazolam and propofol in painless gastrointestinal endoscopy[J].,2022,51(8):753.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.027]
[10]张伟东,李永刚,张 丹,等.基于脑电双频指数反馈下的非肌松闭环靶控镇静在输尿管结石手术中的应用[J].陕西医学杂志,2023,52(8):1047.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.024]
 ZHANG Weidong,LI Yonggang,ZHANG Dan,et al.Application of non-muscular relaxation closed-loop target-controlled sedation based on bispectral index feedback in ureteral calculi surgery[J].,2023,52(8):1047.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.024]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81300969); 山东省自然科学基金资助项目(ZR2020MH130); 山东省医药卫生科研项目(202004070430)
更新日期/Last Update: 2023-08-07